KRMD vs. SIBN, CLPT, BVS, AVNS, ZIMV, BFLY, KIDS, SMLR, CBLL, and TMCI
Should you be buying KORU Medical Systems stock or one of its competitors? The main competitors of KORU Medical Systems include SiBone (SIBN), ClearPoint Neuro (CLPT), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), Butterfly Network (BFLY), OrthoPediatrics (KIDS), Semler Scientific (SMLR), CeriBell (CBLL), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry.
KORU Medical Systems vs. Its Competitors
SiBone (NASDAQ:SIBN) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.
KORU Medical Systems has lower revenue, but higher earnings than SiBone. KORU Medical Systems is trading at a lower price-to-earnings ratio than SiBone, indicating that it is currently the more affordable of the two stocks.
SiBone has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500.
SiBone presently has a consensus price target of $23.67, indicating a potential upside of 63.22%. KORU Medical Systems has a consensus price target of $4.63, indicating a potential upside of 20.13%. Given SiBone's higher probable upside, research analysts clearly believe SiBone is more favorable than KORU Medical Systems.
KORU Medical Systems has a net margin of -12.24% compared to SiBone's net margin of -12.83%. SiBone's return on equity of -14.20% beat KORU Medical Systems' return on equity.
In the previous week, SiBone had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for SiBone and 2 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.35 beat SiBone's score of -0.01 indicating that KORU Medical Systems is being referred to more favorably in the news media.
98.1% of SiBone shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 3.9% of SiBone shares are owned by company insiders. Comparatively, 20.6% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
SiBone and KORU Medical Systems tied by winning 8 of the 16 factors compared between the two stocks.
Get KORU Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
KORU Medical Systems Competitors List
Related Companies and Tools
This page (NASDAQ:KRMD) was last updated on 10/6/2025 by MarketBeat.com Staff
